Phase 2 Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have active rheumatoid arthritis that is not currently in remission, confirmed by a standard joint activity score (called DAS28) above 2.6.
- People who are currently being treated with conventional disease-modifying antirheumatic drugs (a standard class of medication used for rheumatoid arthritis).
- People of any gender.
- People between 18 and 70 years of age.
Who may not be able to join:
- People who have bleeding in the retina (back of the eye) or bleeding in the brain.
- People who have reduced kidney or liver function.
- People who have a known allergy or sensitivity to the medications being used in this trial.
- Women who are pregnant or currently breastfeeding.
- People who are being treated with biological or synthetic disease-modifying antirheumatic drugs (a more advanced class of rheumatoid arthritis medication, different from conventional types).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
change in Disease Activity Score (DAS28)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.